2017

1. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study

   Neurourology and Urodynamics, Vol. 36, Núm. 2, pp. 368-375